Go to Contents Go to Navigation

S. Korea, int'l vaccine institute to strengthen ties

All Headlines 09:34 April 03, 2017

By Kim Han-joo

SEOUL, April 3 (Yonhap) -- South Korea's health ministry signed an agreement with a Seoul-based vaccine research institute Monday to expand cooperation in joint research efforts and to foster experts, officials said.

The memorandum of understanding (MOU) between the Ministry of Health and Welfare, and the International Vaccine Institute (IVI) calls for comprehensive cooperation in research and development (R&D) to make safe and effective vaccines for people in developing countries.

"The ministry believes the MOU will provide growth for South Korea in the vaccine industry since IVI has know-how in areas such as conducting international clinical trials," said a ministry official, who asked not to be named.

Under the terms of the MOU, the ministry pledged full support for IVI's vaccine development, as well as exchanges of experts in the sector.

The IVI is an international organization based in Seoul devoted to developing vaccines against cholera and other kinds of diseases in developing countries. It was established as an initiative of the U.N. Development Program in 1997, and operates under a treaty signed by 40 countries and the World Health Organization.


Send Feedback
How can we improve?
Thanks for your feedback!